Hypertension and Renin-Angiotensin System

Código QR

Hypertension and Renin-Angiotensin System

None

Guardado en:

Detalles Bibliográficos
Autor principal:	Silva, Roberto de Barros
Formato:	Electrónico Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2012
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/34161
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Renin-Angiotensin-Aldosterone System in Dialysis Patients
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Up-Regulation of Renin-Angiotensin System in Diabetes and Hypertension: Implications on the Development of Diabetic Nephropathy
por: Casarini, Dulce Elena, et al.
Publicado: (2012)

Experimental Autoimmune Myocarditis: Role of Renin Angiotensin System
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Renin-Angiotensin System Activation and Extracellular Signal-Regulated Kinases in Glomerulonephritis
por: Urushihara, Maki, et al.
Publicado: (2011)

RENIN-ANGIOTENSIN SYSTEM ROLE IN ARTERIAL HYPERTENSION DEVELOPMENT
por: I. N. Medvedev, et al.
Publicado: (2009-08-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
por: V. I. Podzolkov, et al.
Publicado: (2016-01-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
por: M. L. Kanaeva, et al.
Publicado: (2018-02-01)

Renin-angiotensin-aldosterone system in ISIAH rats with stressinduced arterial hypertension
por: A. D. Dubinina, et al.
Publicado: (2017-02-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
por: A. E. Bragina, et al.
Publicado: (2005-12-01)

Myocardial and Renal Renin–Angiotensin System Enzyme Activity in Dogs
por: Emma C. Weitzhandler, et al.
Publicado: (2025-07-01)

Demonstrating the antinociceptive action of renin-angiotensin system modulators in mice
por: R. N. RUSU, et al.
Publicado: (2018-12-01)

Role of Renin–Angiotensin System and Macrophages in Breast Cancer Microenvironment
por: Abir Abdullah Alamro, et al.
Publicado: (2025-07-01)

Renin–Angiotensin System Autoantibody Network in Parkinson’s Disease Patients
por: Carmen M. Labandeira, et al.
Publicado: (2025-06-01)

Left ventricular hypertrophy: renin4angiotensin system role
por: F. T. Ageev, et al.
Publicado: (2008-04-01)

RENIN ANGIOTENSIN SYSTEM GENE POLYMORPHISMS IN CHILDREN WITH NEPHROTIC SYNDROM
por: Zh.P. Sharnova, et al.
Publicado: (2006-08-01)

Effects of brain renin- angiotensin system inhibition in ISIAH rats with inherited stress-induced arterial hypertension
por: L. O. Klimov, et al.
Publicado: (2017-11-01)

Role of renin-angiotensin-aldosterone system gene polymorphisms in the development of diastolic dysfunction in female patients with hypertension
por: Mariya A. Grenaderova, et al.
Publicado: (2025-01-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM GENES POLYMORPHISM AND RELATION WITH VASOPRESSORS IN ESSENTIAL HYPERTENSION AMONG DAGESTAN INHABITANTS
por: M. Z. Saidov, et al.
Publicado: (2017-05-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
por: Sh. V. Akhadov, et al.
Publicado: (2011-02-01)

RENIN-ANGIOTENSIN PROFILE AND COMPARATIVE EFFECTIVENESS OF FIRST-LINE MEDICATIONS IN MONOTHERAPY OF ESSENTIAL ARTERIAL HYPERTENSION
por: Sh. V. Akhadov, et al.
Publicado: (2010-06-01)

Regulation of Renal Hemodyamics by Purinergic Receptors in Angiotensin II -Induced Hypertension
por: Franco, Martha, et al.
Publicado: (2012)

TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
por: Sh. V. Akhadov, et al.
Publicado: (2009-06-01)

Dynamics of renin-angiotensin-aldosteron system and lipid profile in hypertensive hypothyrosis patients during the process of thyroid function compensation
por: P. Kh. Dzhanashiya, et al.
Publicado: (2004-12-01)

ANALYSIS OF POLYMORPHISMS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND RELATION TO VASOPRESSORS IN ESSENTIAL SYSTEMIC HYPERTENSION WITH THE LEFT VENTRICLE HYPERTROPHY IN DAGESTAN REPUBLIC
por: M. Z. Saidov, et al.
Publicado: (2017-11-01)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
por: N. A. Berezneva, et al.
Publicado: (2013-05-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
por: V. S. Pykhtina, et al.
Publicado: (2015-09-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
por: D. R. Kurbanova, et al.
Publicado: (2009-06-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
por: Shuichi Ichikawa, et al.
Publicado: (2011-06-01)

Renin-angiotensin and kallikrein-kinin systems: a significance in the benign prostatic hyperplasia pathogenesis
por: M. B. Chibichyan, et al.
Publicado: (2019-07-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
por: S. V. Stolov
Publicado: (2020-12-01)

The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
por: Changhui Lang, et al.
Publicado: (2025-07-01)

THE INFLUENCE OF INDAPAMIDE ON BLOOD PRESSURE DAILY PROFILE, HEMODYNAMICS AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS OLDER THAN 55 YEARS
por: S. V. Shlyk, et al.
Publicado: (2002-02-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
por: N. D. Ushakova, et al.
Publicado: (2021-12-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
por: O. V. Taratina, et al.
Publicado: (2014-08-01)

IS IT WORTH TO DISCONTINUE DRUGS BLOCKING THE ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PERI-OPERATIVE PERIOD?
por: V. V. Lomivorotov, et al.
Publicado: (2018-07-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
por: M. L. Maksimov, et al.
Publicado: (2010-04-01)

EVOLUTION STAGES OF LOW RENIN HYPERTENSION
por: S. V. Akhadov, et al.
Publicado: (2016-01-01)

The Renin–Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor
por: Sophia Gagliardi, et al.
Publicado: (2025-07-01)

Renin Inhibitor in Soybean
por: Takahashi, Saori, et al.
Publicado: (2011)

Activity of blood kallikrein-kinin and renin-angiotensin systemsin newborns with hypoxic-ishaemic encephalopathy
por: G. A. Soukhanova, et al.
Publicado: (2007-06-01)